| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | British journal of clinical pharmacology |  | | 2025 | 52 | 0 |
|
| Genetic polymorphisms contributing to hearing loss in children treated with platinum agents : a systematic review and meta-analysis protocol | BMJ open |  | | 2025 | 20 | 58 |
|
| Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients | Therapeutic drug monitoring | | | 2024 | 17 | 96 |
|
| Microcavity-assisted cloning (MAC) of hard-to-clone HepG2 cell lines : cloning made easy | BMC biotechnology | | | 2024 | 26 | 257 |
|
| Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail | Basic & clinical pharmacology & toxicology | | | 2023 | 123 | 0 |
|
| Impact of obesity and bariatric surgery on metabolic enzymes and p-glycoprotein activity using the Geneva cocktail approach | Journal of personalized medicine | | | 2023 | 104 | 60 |
|
| Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways | Frontiers in neuroscience | | | 2022 | 422 | 269 |
|
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | | 2022 | 228 | 419 |
|
| Genetic Susceptibility Toward Nausea and Vomiting in Surgical Patients | Frontiers in genetics | | | 2022 | 245 | 258 |
|
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology and therapeutics | | | 2022 | 183 | 394 |
|
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | | 2021 | 215 | 255 |
|
| Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity | British journal of pharmacology | | | 2021 | 334 | 309 |
|
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | | 2021 | 188 | 422 |
|
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | | 2020 | 341 | 634 |
|
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | | | 2019 | 474 | 4 |
|
| Early biomarker discovery of paracetamol-induced hepato-toxicity after therapeutic doses: experimental tool implementation | | | | 2017 | 113 | 2 |
|
